Seeking AlphaMon, 27 Apr 2026 20:41:40 GMTOruka Therapeutics, Inc. (ORKA) Discusses Interim Results From EVERLAST-A Study of ORKA-001 in Moderate to Severe Plaque Psoriasis TranscriptORKA+0.81%
Seeking AlphaMon, 27 Apr 2026 19:51:39 GMTOruka Therapeutics: 'Strong Buy' On Half-Life Extended IL-23p19 Inhibitor ORKA-001ORKA+0.81%
BenzingaMon, 27 Apr 2026 14:47:53 GMTOruka Therapeutics Stock Explodes As Psoriasis Data Shows 'Highly Compelling' Skin ClearanceORKA+0.81%
The Motley FoolTue, 21 Apr 2026 16:22:39 GMTOruka Insider Sells $463K in Stock as Shares Skyrocket 650%, but Here's What Matters for InvestorsORKA+0.81%
Zacks Investment ResearchTue, 17 Mar 2026 14:55:27 GMTDoes Oruka Therapeutics, Inc. (ORKA) Have the Potential to Rally 41.51% as Wall Street Analysts Expect?ORKA+0.81%
Seeking AlphaWed, 25 Feb 2026 15:03:10 GMTOruka Therapeutics: A Potential Future Psoriasis PlayORKA+0.81%
